MedPath

Heparin-Binding Protein and Heparins

Completed
Conditions
Thromboprophylaxis
Vascular Disease, Peripheral
Cardiovascular Diseases
Interventions
Diagnostic Test: Blood samples for Heparin-binding protein measurement
Registration Number
NCT04146493
Lead Sponsor
Halla Halldorsdottir
Brief Summary

Heparin-Binding protein is a protein from primary and secretory granluae of white blood cells. It is released when white blood cells become activated and has been advocated as a biomarker for sepsis. The aim of this study is to find out if Heparins in clinical doses can change the level of Heparin-binding protein in plasma.

Detailed Description

Blood samples are taken from patients before and after Heparins in clinical doses. The effects of heparins on Heparin-binding protein concentration in plasma is measured. This is a small observational study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Planned endovascular treatment of aortic aneurysm or peripheral vascular surgery where unfractionated heparin in >3000 units are given perioperatively
  • Planned subcutaneous low molecular weight heparin as a thromboprophylactic treatment after major surgery or on Intensive Care treated patients.
  • Planned open heart surgery with cardiopulmonary bypass.
Exclusion Criteria
  • Under 18 years
  • Unable to get informed consent from patient or relative

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Thromboprophylaxis groupBlood samples for Heparin-binding protein measurementPatients which are given low molecular heparins as a thrombosprofylax after major surgery
Vascular surgery groupBlood samples for Heparin-binding protein measurementPatients which are given unfractionated heparin during their vascular surgery.
Cardiothoracic surgeryBlood samples for Heparin-binding protein measurementPatients which are given high dose unfractionated heparin during their open heart surgey
Primary Outcome Measures
NameTimeMethod
Changes in the level of Heparin-binding proteinRepeated blood sampling during minimum of 1 hour and maximum of 5 hours after given heparin

Blood samples are taken before and after given heparin

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Halla Halldorsdottir

πŸ‡ΈπŸ‡ͺ

Stockholm, Solna, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath